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Abstract 
The development, characterisation and application of a new analytical method for 
multi-residue PPCP determination in the freshwater amphipod, Gammarus pulex is 
presented. Analysis was performed using pulverised liquid extraction (PuLE), solid 
phase extraction (SPE) and liquid chromatography-tandem mass spectrometry (LC-
MS/MS). Qualitative method performance offered excellent limits of detection at <20 
ng.g-1 for 18 out of 29 compounds. For quantitative application, linearity and 
precision was considered acceptable for 10 compounds across the ng- -1 range 
(R2 
to the analysis of G. pulex and river water sourced from six tributaries of the River 
Thames. Carbamazepine, diazepam, nimesulide, trimethoprim and warfarin were 
determined in G. pulex samples at low ng.g-1 (dry weight) concentrations across 
these sites. Temazepam and diclofenac were also detected, but were not 
quantifiable. Six pharmaceuticals were quantified in surface waters across the eight 
sites at concentrations ranging from 3-344 ng.L-1. The possibility for confirmatory 
detection and subsequent quantification of pharmaceutical residues in benthic 
organisms such as G. pulex will enable further understanding on the susceptibility 
and ecological effects of PPCPs in the aquatic environment. 
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1. Introduction 
The continuous influx of pharmaceuticals and personal care products 
(PPCPs) into the aquatic environment via wastewater treatment plant (WWTP) 
effluent is driving research into the field of ecotoxicology due to a rising concern for 
the health of biota residing in contaminated waters. Numerous monitoring studies 
have been carried out to assess the extent of PPCP contamination in wastewater 
effluent and impacted surface waters such as rivers, lakes and seawater with PPCP 
L-1 concentrations (Ashton et al., 2004; Behera et al., 
2011; Brown et al., 2006; Carmona et al., 2014; Kosma et al., 2010; McEneff et al., 
2014; Roberts and Thomas, 2006; Thomas and Hilton, 2004; Vazquez-Roig et al., 
2013). The release of pharmaceuticals at low L-1 concentrations has been shown 
to impact on the quality of the surrounding aquatic environment in Europe and 
America (Corcoran et al., 2010; Huerta et al., 2012). However the paradigm of 
transient exposure to temporal flow makes the environmental risk assessment 
complex. Internal concentrations are clearly the key to better understanding (and 
therefore prediction) of risk (Rand-Weaver et al., 2013). The exposure of wild-caught 
and caged biota to contaminated surface waters over extended periods of time have 
revealed the potential for PPCP uptake and subsequent adverse chronic effects 
(Dodder et al., 2014; Gatidou et al., 2010; Huerta et al., 2013; Subedi et al., 2012). It 
is widely believed that bioaccumulation of contaminants occurs through passive 
diffusion where the hydrophobicity of the compound (logP) largely describes their 
permeability through membranes (Hamelink and Spacie, 1977; McKim et al., 1985). 
However, due to their ability to ionise and undergo various transformation processes, 
there is mounting evidence to support carrier mediated transport of PPCPs through 
facilitated diffusion and active transport (Dobson and Kell, 2008; Schultz et al., 
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2010).  PPCP occurrence data in aquatic biota is of particular importance as results 
may highlight highly bioaccumulative compounds that may direct the attention of 
future risk assessment and management strategies for PPCPs. Furthermore, and 
given that several thousand pharmaceutical compounds currently exist on the 
market, this represents a significant challenge. It is of interest to enable discovery of 
PPCPs in the environment, which might not otherwise be predicted using simple 
logP-based approaches and analytical methods to detect these are urgently required 
to aid in prioritisation efforts. 
Aside from localised monitoring programmes, the only international body in 
the EU to recognise PPCPs as an emerging environmental concern was, until 
recently, the Oslo-Paris Convention for the Protection of the Marine Environment of 
the North-East Atlantic (OSPAR) Commission. Pharmaceuticals remained outside 
the scope for regulation and formal monitoring under the European Water 
Framework Directive (WFD). However, following the results of numerous European 
monitoring studies at a national level, the list of priority pollutants has recently been 
anti-inflammatory, dicl - -
estradiol, which are not subject to regulation, but are instead closely monitored in EU 
surface waters for possible future addition to the priority list (Commission, 2012).  
Gammarus pulex has many attributes for use in biomonitoring studies. It is a 
freshwater benthic dwelling detritivore which has an important role in freshwater food 
chains as a food source for other invertebrates, fish and birds (Friberg et al., 1994; 
Maltby et al., 2002). G. pulex is widely distributed in freshwater rivers and tributaries 
across Europe and can be collected in large numbers using simple kick sampling 
techniques. More importantly G. pulex has already been used as a model organism 
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for assessing both the adverse effects (Lange et al 2006; 2009) and uptake potential 
of PPCPs (Meredith-Williams et al., 2012) as well as other common pollutants 
(Ashauer et al., 2012; Nyman et al., 2012). The main disadvantage of using G. pulex 
in biomonitoring is their small size which poses a significant analytical challenge for 
multi-residue screening. A trade-off exists between achieving suitable method 
sensitivity and using the minimum number of specimens to make a single 
measurement. Very few methods exist for PPCP residue analysis of such small 
species in the aquatic environment. It is generally accepted that liquid or gas 
chromatography coupled to mass spectrometry offers the sensitivity and selectivity 
required. It has been successfully applied to the analysis of other smaller 
invertebrate species such as Chironomus tentans and Hyallela azteca (Dussault et 
al., 2009; Klosterhaus et al., 2013). However, robust analytical methods to determine 
PPCP residue occurrence in G. pulex are still lacking. 
This paper presents, for the first time, the occurrence and relative distribution 
of PPCPs in surface waters and G. pulex collected from several tributaries located in 
the greater London catchment area. The aim of this study was to evaluate the extent 
of contamination in surface waters flowing into the River Thames and to investigate 
the potential for the crustacean, G. pulex, to be utilised in future monitoring studies 
as an indicator for PPCP pollution. 
 
2. Materials and Methods 
 
2.1 Reagents, chemicals and consumables  
HPLC grade methanol, acetonitrile, acetone, ethyl acetate, dichloromethane and 
dimethyldichlorosiloxane were purchased from Fischer Scientific (Loughborough, 
UK). Analytical grade ammonium acetate was sourced from Sigma-Aldrich (Dorset, 
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UK). Propranolol hydrochloride, ketoprofen, diclofenac sodium salt, bezafibrate, 
warfarin, flurbiprofen, indomethacin, ibuprofen sodium salt, meclofenamic acid 
sodium salt, gemfibrozil, atenolol, sulfamethoxazole, sulfamethazine sodium salt, 
furosemide, carbamazepine, nimesulide, (±)-metoprolol (+)-tartrate salt, triclocarban,  
cimetidine, ranitidine, antipyrin, temazepam, diazepam, fluoxetine, nifedipine and 
mefenamic acid were all obtained from Sigma-Aldrich (Steinheim, Germany). 
Trimethoprim, caffeine, and naproxen were ordered from Fluka (Buchs, Switzerland). 
Stable isotope-labelled standards including carbamazepine-d10, propranolol-d7, 
temazepam-d5 and diazepam-d5 were ordered from Sigma-Aldrich. Trimethoprim-d3 
and warfarin-d5 were ordered from QMX Laboratories (Essex, UK). All 
pharmaceuticals were -pure water was obtained from a 
Millipore Milli-Q water purification system with a specifi .cm or 
greater (Millipore, Bedford, MA, USA). Stock solutions (1 mg.mL-1) were prepared in 
methanol and stored in silanised amber vials (40 mL). Working solutions were 
prepared daily in ultra-pure water, as required. All solutions were stored at 4 oC and 
in the dark for optimum stability. 
 
2.2 Sample collection and preparation 
Gammarus pulex and surface waters were sourced from eight tributaries of the River 
Thames, UK. These were spread across the greater London catchment area and 
included the River Wandle (Sites 1 and 2), the River Quaggy (Site 3), the River 
Ravenstone (Site 4), the River Cray (Sites 5 and 6), the River Darent (Site 7) and 
Beverley Brook (Site 8). The specific locations of the selected sites are shown in 
Figure 1. Adult specimens were collected in September 2012 via the kick sampling 
netting method and weighed >5 mg (wet weight). Samples were transported back to 
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the laboratory in NalgeneTM flasks containing 500 mL of freshwater obtained from 
each corresponding sampling site. A bulk sample of G. pulex from Site 1 was used in 
all analytical method optimisation experiments and was taken six months prior to 
samples from the same site used for analyte reporting. G. pulex were wiped free of 
debris, rinsed immediately with ultra-pure water (n=3) and gently blotted dry before 
freezing at -20 oC. A separate 1 L grab sample of surface water at each site was also 
collected and transported back to the laboratory in 500 mL NalgeneTM flasks. Water 
samples were also frozen at -20 oC until analysis. All glassware was washed in 
HPLC-grade solvents prior to use and on a monthly basis silanised by washing each 
vessel with 10 % (v/v) dichlorodimethylsilane solution in dichloromethane (n=3) and 
followed by a sequence of triplicate rinses with each of dichloromethane, methanol 
and ultrapure water respectively. 
 
2.3 Sample extraction and clean-up 
Prior to extraction, frozen G. pulex samples were freeze-dried at -50 oC under 
vacuum for 24 hours and ground into a coarse material using a clean pestle and 
mortar. Pulverised liquid extraction (PuLE) was performed on an Ultra-Turrax® tube 
driver (IKA, Staufen, Germany). The tube driver was used with an extraction vessel 
for sample homogenisation and extraction. The contents of the extraction tube were 
agitated and pulverised at a set rate by means of a rotor and glass beads located 
inside the tube. For each analysis, freeze-dried composite sample material from 
each sampling site (0.1 g) was transferred to a 20 mL extraction tube (IKA) with any 
n
an appropriate working solution followed by 5 mL of acetonitrile. Two glass beads 
(diameter = 5 mm) were then added to the extraction tube to enable further 
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pulverisation of the sample and the tube agitated at 2,500 rotations per minute (rpm) 
for 5 minutes (optimised). Following extraction and settling, an aliquot of the 
supernatant (4.5 mL) was diluted to 100 mL with 10 mM ammonium acetate in ultra-
pure water (pH 6.5). Solid phase extraction (SPE) was then carried out as in 
previously published work on a similar selection of compounds (Barron et al., 2008) 
on the diluted sample using Oasis HLB cartridges (6 mL, 200 mg, Waters Corp., 
Hertfordshire, UK). Before loading of the sample, SPE cartridges were first 
conditioned with 6 mL of methanol and 6 mL of ultra-pure water. After sample 
extraction, cartridges were then washed with 1 mL ultra-pure water and dried for ~30 
min under vacuum. Sample extracts were eluted with 10 mL of 50:50 (v/v) ethyl 
acetate:acetone and dried under pure nitrogen (1.0 bar) and heated at 30 oC using a 
TurboVap (Biotage, Uppsala, Sweden). Extract residues were reconstituted in 0.5 
mL 90:10 (v/v) 10 mM ammonium acetate in water:acetonitrile. Surface water 
samples (100 mL) were adjusted to pH 6.5 with ammonium acetate (1 mL of a 1 M 
solution). Water samples then underwent SPE and reconstitution as described 
above. Any necessary spiking or liquid volume measurements were carried out using 
positive displacement pipettes (Gilson Microman, Villiers-le-Bel, France). 
 
2.4 Instrumental conditions 
A previously published chromatographic method for the analysis of PPCPs in soil 
and sludge was adapted and applied to a biological matrix (G. pulex) (Barron et al., 
2008). Briefly, liquid chromatography (LC) was performed on an Agilent 1100 series 
LC system (Agilent Technologies, Cheshire, UK) using a Waters SunFire C18 column 
TM 
Ultra guard column (0. d, UK) at a 
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flow rate of 0.2 mL.min-1 
90:10 (v/v) 10 mM ammonium acetate in water:acetonitrile (A) and 20:80 (v/v) 10 
mM ammonium acetate in water:acetonitrile (B). The profile followed a linear ramp of 
mobile phase B which increased to 10 % at 5 min, 35 % at 28 min, 40 % at 35 min, 
50 % at 40 min and 100 % at 55 min and was held for a further 7.5 min before 
returning to initial conditions. Re-equilibration time was 12.5 min resulting in an 
overall run time of 75 min. Detection and quantification was carried out with a Waters 
Quattro triple quadrupole mass spectrometer (Waters Corp., Milford, MA, USA) 
equipped with an atmospheric pressure interface-electrospray ionisation (API-ESI) 
source. Mass spectrometric (MS) analysis was carried out in selected reaction 
monitoring (SRM) mode using positive-negative ionisation polarity switching. A scan 
rate of 0.03 min was utilised with a minimum of 15 points per peak measuring ±0.5 
mass units for all transitions monitored. Confirmation of the selected compounds was 
achieved using both retention time and two transitions (MSn2 fragment ions where 
possible) with the most intense fragment ion selected for analyte quantification 
(Table 1). MS conditions as well as all SRM transitions are summarised in Tables S1 
and S2 of the supplementary information and were determined by direct infusion 
using a syringe pump which delivered 300 mL.h-1 of analyte solution. 
 
2.5 Method performance characteristics and quality control 
For this study, method performance characteristics are presented for G. pulex 
only..Matrix-matched calibration curves were generated for biota to assess method 
performance. Linearity was determined by measuring the peak area at 
concentrations from 0.01 to 10 µg.g-1 for the G. pulex  for each compound). 
Limits of detection (LODs) were determined as the lowest concentration of analyte 
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which produced a signal-to-noise (S/N) ratio of 3:1. Limits of quantification (LOQs) 
were determined as that analyte concentration to give an S/N ratio of 10:1. Both LOD 
and LOQ were calculated using the S/N ratios of low concentration spiked samples 
and precision checked at this level for n=6 replicates to ensure satisfactory 
performance. Instrumental retention time and method precision (intra-day) 
experiments were performed for n=6 replicate injections of a biotic sample spiked at 
1 µg.g-1. Method accuracy (intra-day) was determined using a biotic sample spiked 
at 20 ng.g-1 for all compounds except for sulfamethazine, metoprolol, propranolol, 
nimesulide and nifedipine, where the biotic sample was spiked at 75 ng.g-1 
Recovery was determined by comparing spiked samples at 1 µg.g-1 in G. pulex (n=6 
and which was also used to assess mid-range method precision) to sample extracts 
spiked post-extraction (n=3) at the expected final concentration. Control samples 
were also analysed for background correction purposes, where necessary. The 
measurement of ion suppression or enhancement in ESI-MS involved the 
comparison of sample extracts spiked post-extraction to a 100 ng.g-1 working 
solution mixture (n=3). The target analytes in both surface waters and biota were 
quantified based on their peak areas relative to that of an isotopically-labelled 
internal standard or, where unavailable, by external matrix-matched calibration. 
Relative recovery in G. pulex was measured following the analysis of spiked biotic 
samples (analytes and the internal standard at 100 ng.g-1 each) by comparing the 
analyte peak areas to that of the internal standard (n=12).  
Mobile phase A was injected between samples from each site as well as 
between matrix-matched standards and controls to minimise the possibility of carry 
-1) was carried out before 
each batch analysis to ensure that the MS was operating satisfactorily. None of the 
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targeted analytes were detected in any solvents, reagents or ultra-pure water used in 
this study.  
 
3. Results and Discussion 
3.1 Optimisation of analytical methods for G. pulex  
The presence of pharmaceuticals in aquatic organisms, particularly molluscs, has 
been previously investigated using extraction techniques such as pressurised liquid 
extraction (PLE) or ultrasound-assisted solvent extraction which involve the use of 
high temperatures, pressures and/or relatively large volumes of organic solvent  
(Cueva-Mestanza et al., 2008; McEneff et al., 2013). Other studies have utilised 
PuLE as a simple and fast extraction method for the quantification of 
pharmaceuticals in solid dosage forms (Kok and Debets, 2001). Due to the 
complexity of biological tissues (and especially here where keratinous material was 
present), PuLE was used here to simultaneously blend and extract all material 
before SPE. For this purpose, a specially designed extraction vial was used and was 
equipped with a rotor for agitation of the sample, liquid and two glass beads. The 
beads were required for satisfactory agitation and pulverisation of the G. pulex 
material, but also were considered valuable to potentially confer flexibility in the 
future for extraction of whole tissues/specimens where necessary. Sorption to glass 
beads was briefly investigated here by performing the extraction procedure on a 
mixed 1 µg.mL-1 standard solution of all analytes prepared in the extraction solvent. 
The use of silanised glass beads did not yield higher analyte recoveries than those 
achieved using unsilanised glass beads. Therefore, glass bead silanisation was not 
required (see Table S2).  
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The extraction of pharmaceuticals from aqueous samples is generally 
performed by SPE and HLB-type SPE cartridges enable the extraction of both polar 
and non-polar compounds from both water and biological extracts (Baker and 
Kasprzyk-Hordern, 2011a; Barron et al., 2008; Gomez et al., 2006; Weigel et al., 
2004). The effect of the sample pH prior to SPE was investigated at pH 2, 7 and 10 
(n=3). A sample pH of 7 yielded the highest recoveries and lowest variability for the 
selected analytes. Sample reconstitution volumes of 0.1 mL and 0.5 mL were also 
investigated. As shown in Table S4, analyte recovery using a reconstitution volume 
of 0.5 mL was higher overall than that of 0.1 mL. In particular, compounds such as 
diazepam, gemfibrozil, triclocarban, ibuprofen, diclofenac and nimesulide showed 
moderately higher recoveries when reconstituted to 0.5 mL. Solubility of a dried 
matrix residue may have been a limiting factor at the reduced reconstitution solvent 
volume. Furthermore, matrix suppression effects in ESI-MS are likely to increase 
with a more concentrated sample extract (as was observed here). Although a 
thorough sample clean-up method was developed, final extracts of the G. pulex 
contained an immiscible red-pigmented liquid. A likely identity for this contaminant is 
astaxanthin, a relatively non-polar carotenoid pigment found in crustaceans 
(Johnson and An, 1991), but further analysis would be required to confirm this. 
Attempts to remove this substance from the ground G. pulex sample via liquid-liquid 
extraction (using a 50:50 (v/v) solution of acetonitrile with hydrochloric acid at pH 2 
and hexane) did not prove successful. Additional approaches such as centrifugation 
and neutral alumina addition were also investigated (the latter of which is often used 
to remove pigments), but the substance remained in the sample extract and analyte 
recoveries did not improve (data not shown). Therefore, a 0.5 mL reconstitution 
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volume in 90:10 (v/v) 10 mM ammonium acetate in water:acetonitrile was considered 
optimised. 
In line with many other studies, LC-MS/MS was the chosen analytical 
technique for the confirmatory detection and subsequent determination of PPCPs in 
surface waters and G. pulex. A 10 mM ammonium acetate solution in a mixture of 
acetonitrile and water was selected again as a suitable mobile phase for reversed-
phase separations in line with previously published work (Barron et al., 2008). The 
mobile phase gradients and column temperature (20, 30, 40 and 45 °C) were further 
optimised to allow better separation of more PPCPs. An column oven temperature of 
45 °C offered the best separation of all compounds. For mass spectrometry, direct 
infusion was carried out initially in full scan mode to determine the most abundant 
precursor ion for each analyte and to optimise MS parameters for the best signal 
response. Compounds yielded [M+H]+, [M-H]- or [M-COOH]- precursor ions in 
positive or negative polarity ESI-MS mode. Furthermore, SRM performed under 
positive-negative switching mode yielded MS/MS data for 29 analytes (Table S2). 
Secondary fragment ion transitions were observed for 21 of these compounds. 
 
3.2 Method performance characteristics  
Few validated multi-residue methods exist for PPCP determination in biota due to 
their complexity, variability, and potential to cause analytical matrix effects. 
Therefore, a larger number of compounds were included in the method development 
process originally as it was expected that some would not meet acceptable method 
performance criteria for quantitative analysis of small biotic samples. Those 
considered acceptable are presented in Table 1 (data from the full method 
performance experiment are shown in Tables S4 and S5).  Method performance in 
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surface waters is not presented here, but the method was deemed suitable for semi-
quantitative purposes as it was based on previously published work (Lacey et al., 
2012; Lacey et al., 2008). Instrumental retention time precision in G. pulex matrix 
was <0.5 % for all analytes except for propranolol which was 1.7 % (n=6). For 
method linearity, correlation coefficients of R2 
for triplicate experiments, again in G. pulex matrix, over the calibration range for 18 
compounds. Twelve compounds achieved unacceptable correlation coefficients and 
were included for qualitative purposes only (Table S5). Following the assessment of 
linearity, limits of quantitation (LOQs) of the method were determined for 23 analytes 
and lay between 4-687 ng.g-1. Intra-day method reproducibility was <30 % for 20 
analytes . Mean absolute recoveries of 28 analytes ranged from 4-89 % 
(n=6) with eight compounds displaying absolute recoveries >70 %. Overall, it was 
observed that compounds determined in negative ESI-MS mode demonstrated lower 
recoveries than compounds detected in positive ESI-MS mode. Significant signal 
suppression was observed in G. pulex matrix as per Table S4 and signals for 6 of 29 
compounds were suppressed greater than 50 % in comparison to a standard 
mixture. The precision and recovery of this method in G. pulex correlates to data 
reported by Klosterhaus et al. (2013) for the analysis of PPCPs in mussels from San 
Francisco Bay. Other similar studies carried out on mussel and fish tissues, and 
other complex matrices such as biosolids and sludge, have shown similar method 
performance for PPCPs (Dodder et al., 2014; McEneff et al., 2013). Overall, and of 
the 29 PPCPs initially included in method development and performance 
characterisation, 10 compounds (carbamazepine, trimethoprim, warfarin, diazepam, 
temazepam, propranolol, nifedipine, nimesulide, sulfamethazine and metoprolol) 
showed acceptable method performance for quantification purposes. Precision was 
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also maintained for these compounds when measured near the LOQ across n=6 
replicates. 
 
3.3 Application to G. pulex and surface waters in tributaries of the River Thames, UK 
The developed methods were applied to the identification of pharmaceutical residues 
in water and biotic samples. Surface water samples (500 mL) and G. pulex -
100 specimens) were used for replicate analysis across the selected sites. As the 
surface water and biotic samples were collected by grab sampling, the results 
presented represent pharmaceutical concentrations present at that point in time. 
Example extracted ion chromatograms for compounds quantified in surface waters 
and G. pulex, are shown in Figure 2. 
Of the 29 compounds included in the analytical method for qualitative 
screening of invertebrate tissues, a total of 6 compounds were quantified in G. pulex 
(Table 2). Diclofenac was also detected at all sites but was not quantifiable due to 
method performance limitations (Table S5). Due to the lack of information regarding 
pharmaceutical uptake in G. pulex, similar occurrence studies on other species were 
used for comparison. Five compounds were quantified across the eight sites at 
-1 dry weight (Table 2). Carbamazepine was the most 
frequently detected compound, which is perhaps unsurprising as this compound has 
been reported in several solid and biological matrices (Barron et al., 2008; Huerta et 
al., 2013). Site 7 was the most contaminated of all sites. Diazepam was quantifiable 
across four sites at conc -1 dry weight. Kwon and co-workers 
detected several PPCP residues including carbamazepine and diazepam in fish 
livers and the latter was determined at concentrations up to 110 ng.g-1 wet weight 
(Kwon et al., 2009). If hydrophobicity is to be considered a reliable quantity for 
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bioaccumulation of PPCPs, then this may be explained given their moderate 
hydrophobicity relative to other PPCPs (logP=2.45 and 2.86, respectively) (Barron et 
al., 2009). However, Meredith-Williams et al. recently studied bioconcentration of 
diazepam and carbamazepine in G. pulex, both of which were found to be minimal 
with BCF values of 38 and 7, respectively. As these compounds have relatively 
higher logP values in comparison to most other pharmaceuticals, it suggests that 
uptake models based on hydrophobicity may not accurately represent the potential 
for a compound to bioconcentrate in invertebrates. Tanoue et al. recently presented 
an analytical method for the determination of 17 intermediate-polarity PPCPs 
(logP=1.40 5.74) and its application to biological tissue from Japanese fish and birds 
(Tanoue et al., 2014). Up to 13 PPCPs were determined across fish plasma (0.03-22 
ng.mL-1), brain and liver tissue (1-910 and 0.11-16 ng.g-1 wet weight respectively) 
and all 17 were detected in the surrounding aquatic environment (at 3-871 ng.L-1). 
McEneff et al. investigated pharmaceutical concentrations in marine bivalves 
residing in effluent-contaminated seawater. The antibiotic, trimethoprim, measured 
highest at concentrations up to 9 ng.g-1 dry weight and carbamazepine was also 
detected, but below its LOQ (McEneff et al., 2014). Here, trimethoprim was only 
quantifiable at Site 8 at 5 ng.g-1 dry weight. Nimesulide was quantified at slightly 
higher concentrations on average. This coincides with the results from surface water 
analysis where nimesulide was detected in samples from Sites 1 4 and 7. 
Nimesulide was banned in the Republic of Ireland in 2007 due to risks associated 
with hepatic failure and it is not available on the UK market as a pharmaceutical for 
human consumption. However, sources of input into the environment still exist via 
veterinary routes and in addition this compound has also been found in selected food 
supplements (Lacey et al., 2012; MHRA, 2014).  
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Adverse effects such as increased oxidative stress and tissue lesions have 
been observed following the exposure of species such as fish and molluscs to 
environmentally relevant PPCP concentrations. A study carried out by De Lange et 
al. (2006) investigated the behavioural responses of G. pulex when exposed to 
environmentally relevant concentrations (from 0.1 ng.L-1 up to 1 mg.L-1) of the 
pharmaceuticals carbamazepine, fluoxetine and ibuprofen (De Lange et al., 2006). 
The lowest observed effect concentration (LOEC) for fluoxetine was reported as 100 
ng.L-1 and the LOEC for ibuprofen and carbamazepine was measured at even lower 
concentrations at 10 ng.L-1. However, it was noted that the reduced activity observed 
in G. pulex -1) was not significantly different to 
the control exposure. Carbamazepine was measured at concentrations up to 344 
ng.L-1 in the surface waters from Site 8. Further work is still required to establish 
reliable LOEC levels for pharmaceuticals both in isolation and when present as a 
mixture (Arnold et al., 2014; Brooks, 2014). Indeed, with ongoing extensive debate in 
the literature questioning the validity and reproducibility of experiments revealing 
effects on bespoke endpoints (Sumpter et al., 2014), it is clearly essential to have 
the tools available to measure both the exposure concentrations (water) and internal 
concentrations in order to attribute cause and effect.  
With respect to surface waters, six PPCPs were detected at quantifiable 
levels across all sites at concentrations ranging from 3-344 ng.L-1 (Table 3). 
Carbamazepine and trimethoprim measured highest at concentrations of 344 ng.L-1 
and 289 ng.L-1, respectively. From the eight sites, all of the selected analytes 
measured at their highest concentration at Site 8, with the exception of propranolol 
which measured at concentrations >250 ng.L-1 at Site 5. An effluent outfall pipe lay in 
close proximity to Site 8, and potentially higher concentrations of pharmaceutical 
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contamination in river water were measured as a result. However, this did not 
translate across to elevated concentrations measured in G. pulex (highest internal 
concentrations measured at Site 7). The Beverley Brook tributary was previously 
failures in surrounding ecology, water chemistry and morphology standards 
(Ehmann, 2013). River water samples from Site 5 were also found to contain 
relatively high concentrations of carbamazepine, propranolol and trimethoprim. 
Besides direct input from WWTPs, other sources of pharmaceutical contamination 
include sewage from the numerous combined sewer overflows serving this river 
catchment area which overflow during periods of heavy rainfall and interestingly, 
have been shown to intermittently discharge sewage into surface waters even 
without precipitation (Buerge et al., 2006). The UK Environment Agency has reported 
poor status for two groundwater bodies which predominantly supply the river flow 
through Sites 5, 6 and 7 (Gorman, 2013). Although most of the PPCPs were 
detected at all three of these sites, surface water samples from the River Cray (Sites 
6 and 7) were found to contain relatively low residue concentrations overall. 
Diazepam was the least detected compound in water and measured concentrations 
were 3 and 4 ng.L-1 at Sites 3 and 8, respectively.  
between water and G. pulex measured concentrations (compare Tables 2 and 3). 
Temazepam and propranolol were both measured in water (propranolol in 7 of the 8 
sites), but neither were detected within any G. pulex despite having higher LogP 
values than trimethoprim which was measured in these organisms. This would 
further support the hypothesis that for invertebrates, uptake is driven by more than 
hydrophobicity alone. Intuitively one would predict a constant state of flux in the 
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uptake and depuration of compounds as the flow of water and external exposure 
changes, and the poor correlation could support that. Therefore, measuring 
concentrations within the organism is likely to be more relevant (and important) for 
understanding risk than external water alone.  
Several monitoring studies have been carried out in freshwater throughout the 
UK. A study carried out on the River Taff and the River Ely in Wales consistently 
detected the presence of carbamazepine at concentrations up to 684 ng.L-1. Several 
recent monitoring studies have detected the presence of propranolol and 
trimethoprim in surface waters across the UK at concentrations up to 40 ng.L-1 and 
215 ng.L-1, respectively (Ashton et al., 2004; Baker and Kasprzyk-Hordern, 2011b; 
Roberts and Thomas, 2006). The benzodiazepines, temazepam and diazepam have 
also been reported in river water measuring at concentrations of 53 ng.L-1 and 1 
ng.L-1, respectively (Baker and Kasprzyk-Hordern, 2011a). All six selected 
pharmaceuticals detected here have also been determined in river waters around 
-1 in countries such as 
South Korea, Spain and France (Feitosa-Felizzola and Chiron, 2009; Silva et al., 
2011; Yoon et al., 2010).  
 
4. Conclusions 
For the first time, the occurrence of six pharmaceuticals was reported from 
measured internal concentrations in the river shrimp, G. pulex, and its surrounding 
waters. An analytical method involving PuLE, SPE and LC-MS/MS was optimised 
and applied to surface waters and G. pulex samples collected from eight sites along 
several tributaries of the River Thames. Five pharmaceuticals detected in the 
freshwater samples were also found to occur in exposed G. pulex at concentrations 
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up to 36 ng.g-1 dry weight, although direct correlation with water concentrations at 
individual sites was not possible. Carbamazepine and trimethoprim measured 
highest in river water at concentrations up to 344 ng.L-1 and 289 ng.L-1, respectively. 
These findings provide new knowledge on the occurrence of pharmaceutical 
residues in a key aquatic invertebrate, and tools to further investigate their potential 
effects via internal concentration measurement. 
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Figure 1. Locations from which samples of G. pulex and surface waters were collected. Site 1 and 2 -
River Wandle, Site 3  River Quaggy, Site 4  River Ravensbourne, Site 5 and 6  River Cray, Site 7 
 River Darent, Site 8  Beverley Brook . Map used with permission and contains Environment 
Agency information (© Environment Agency and database right). 
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Figure 2. Example extracted ion chromatograms of PPCPs detected in surface waters and G. pulex 
sampled from each of the eight selected sites  
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